Compare Medpace Holdings Inc (MEDP) vs Rent the Runway Inc (RENT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medpace Holdings Inc vs Rent the Runway Inc — how do they compare? Medpace Holdings Inc trades at $612.05 (market cap $16.82B), while Rent the Runway Inc trades at $1.77 (market cap $61.75M). The key difference: Medpace Holdings Inc is far larger — about 272.4× Rent the Runway Inc's market cap, and Medpace Holdings Inc is trading nearer its 52-week high, Rent the Runway Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Medpace Holdings Inc for 14 Days and Rent the Runway Inc for 56 Days on average.
| MEDP | RENT | |
|---|---|---|
Market Cap | $16.82B | $61.75M |
Volume | 223,093 | 193,323 |
Sector | Health | Consumer Cyclical |
52-Week High | $630.19 | $9.39 |
52-Week Low | $393.42 | $1.55 |
Typical Hold Time | 14 Days | 56 Days |
Enterprise Value | $16.44B | $228.75M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Medpace (MEDP) trades at $602.70, down 0.26% with neutral technical signals. The stock shows strong fundamentals with consistent earnings beats (Q4 2025-Q2 2026) and robust profitability (17.67% net margin, 162.15% ROE). Recent CEO stock sales and mixed institutional activity create near-term uncertainty, though analyst consensus remains positive with a $620.44 price target. The company is scheduled to report Q3 2026 results on October 21, 2026.
MEDP presents a compelling growth story with strong financial metrics, though elevated valuations (P/E 35.41) and insider selling warrant caution. Upside potential exists if Q3 earnings meet expectations, while failure to maintain growth momentum could pressure the stock. The current price near pivot point ($599) suggests balanced risk-reward ahead of earnings.
Rent the Runway (RENT) trades at $1.83, up 8.93% today, with a bullish technical signal despite mixed moving averages and oscillators. The company reported Q2 2026 revenue growth of 20.8% year-over-year to $97.7 million, with improving gross margins, and appointed Paige Thomas as CEO. However, the stock faces negative shareholder equity of -$182.5 million and a high debt-to-asset ratio of 139.62% as of 2025, though 2026 projections show a return to net profitability.
The outlook is cautiously optimistic, with analyst consensus at 42.1% buy ratings and no sell ratings, but legal investigations and high leverage pose significant risks. Revenue growth and margin expansion are key catalysts, yet investor confidence is tempered by ongoing financial instability and negative equity.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Medpace Holdings Inc
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →About Rent the Runway Inc
Rent the Runway Inc is an e-commerce platform that allows users to rent, subscribe, or buy designer apparel and accessories.
Read more on RENT →
